FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018010902> ?p ?o ?g. }

• W2018010902 endingPage "146" @default.
• W2018010902 startingPage "141" @default.
• W2018010902 abstract "The efficacy and safety of a 3-day regimen of azithromycin prescribed in the new tablet form and of a 10-day regimen of amoxycillin–clavulanic acid (co-amoxiclav, Augmentin®) were compared in patients with acute lower respiratory tract infections. Of the 144 enrolled patients, 123 had a Type 1 acute exacerbation of chronic bronchitis (AECB), three patients had pneumonia, and 18 had purulent bronchitis. Treatment was successful, defined as cure or major improvement on day 14, in 59/62 (95%) patients in the azithromycin treatment group compared with 54/61 (90%) patients in the co-amoxiclav. At 30 days, the incidence of success was 77% (48/62) in the azithromycin treated group, compared with 66% (40/61) of co-amoxiclav-treated patients. At 60 days, incidences were 66% (41/62) and 59% (36/61), respectively. Several pathogens were isolated: Haemophilus influenzae in 21 patients (minimum inhibitory concentration (MIC) range for azithromycin 0.12–4 mg/l; co-amoxiclav 0.25–4 mg/l); Streptococcus pneumoniae in nine (MIC azithromycin ≤0.06≥256 mg/l; co-amoxiclav ≤0.06–1 mg/l); and Moraxella catarrhalis in 11 (MIC azithromycin ≤0.06–2 mg/l; co-amoxiclav ≤0.06–0.5 mg/l). Microbiological response rates were comparable. A significant correlation between clinical and microbiological cure was found (p=0.02, power 0.6). In 15 (10%) patients, positive serology for viruses or atypical pathogens was found. In the co-amoxiclav-treatment group, 24 patients had mild adverse events (12 diarrhoea), compared with 27 treated with azithromycin (p=0.47). It is concluded that a 3-day regimen of azithromycin prescribed as tablets is as clinically and microbiologically effective as a 10-day regimen of co-amoxiclav in the treatment of acute lower respiratory tract infections. Moreover, since the percentage of viral infections was low and a significant correlation between microbiological and clinical cure was found, this study shows that clinical symptoms can be used to establish which patients with AECB (Type 1) should be treated with antimicrobial agents." @default.
• W2018010902 created "2016-06-24" @default.
• W2018010902 creator A5010649525 @default.
• W2018010902 creator A5025987396 @default.
• W2018010902 creator A5026745019 @default.
• W2018010902 creator A5028300999 @default.
• W2018010902 creator A5033993903 @default.
• W2018010902 creator A5039813863 @default.
• W2018010902 creator A5040668716 @default.
• W2018010902 creator A5047624818 @default.
• W2018010902 creator A5061545775 @default.
• W2018010902 creator A5076901379 @default.
• W2018010902 creator A5083649573 @default.
• W2018010902 date "1998-01-01" @default.
• W2018010902 modified "2023-09-24" @default.
• W2018010902 title "A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin–clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome" @default.
• W2018010902 cites W1974194369 @default.
• W2018010902 cites W1991988131 @default.
• W2018010902 cites W2002847765 @default.
• W2018010902 cites W2012519534 @default.
• W2018010902 cites W2013901116 @default.
• W2018010902 cites W2066926630 @default.
• W2018010902 cites W2074591551 @default.
• W2018010902 cites W2076574401 @default.
• W2018010902 cites W2089495402 @default.
• W2018010902 cites W2093337868 @default.
• W2018010902 cites W2105872313 @default.
• W2018010902 cites W2118250005 @default.
• W2018010902 cites W2123791078 @default.
• W2018010902 cites W2142077833 @default.
• W2018010902 cites W2160967947 @default.
• W2018010902 cites W4231394082 @default.
• W2018010902 cites W4244703446 @default.
• W2018010902 doi "https://doi.org/10.1016/s0924-8579(97)00043-5" @default.
• W2018010902 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9552709" @default.
• W2018010902 hasPublicationYear "1998" @default.
• W2018010902 type Work @default.
• W2018010902 sameAs 2018010902 @default.
• W2018010902 citedByCount "66" @default.
• W2018010902 countsByYear W20180109022012 @default.
• W2018010902 countsByYear W20180109022013 @default.
• W2018010902 countsByYear W20180109022014 @default.
• W2018010902 countsByYear W20180109022015 @default.
• W2018010902 countsByYear W20180109022017 @default.
• W2018010902 countsByYear W20180109022019 @default.
• W2018010902 countsByYear W20180109022020 @default.
• W2018010902 countsByYear W20180109022022 @default.
• W2018010902 crossrefType "journal-article" @default.
• W2018010902 hasAuthorship W2018010902A5010649525 @default.
• W2018010902 hasAuthorship W2018010902A5025987396 @default.
• W2018010902 hasAuthorship W2018010902A5026745019 @default.
• W2018010902 hasAuthorship W2018010902A5028300999 @default.
• W2018010902 hasAuthorship W2018010902A5033993903 @default.
• W2018010902 hasAuthorship W2018010902A5039813863 @default.
• W2018010902 hasAuthorship W2018010902A5040668716 @default.
• W2018010902 hasAuthorship W2018010902A5047624818 @default.
• W2018010902 hasAuthorship W2018010902A5061545775 @default.
• W2018010902 hasAuthorship W2018010902A5076901379 @default.
• W2018010902 hasAuthorship W2018010902A5083649573 @default.
• W2018010902 hasConcept C126322002 @default.
• W2018010902 hasConcept C2776551000 @default.
• W2018010902 hasConcept C2778907293 @default.
• W2018010902 hasConcept C2779454058 @default.
• W2018010902 hasConcept C2779708577 @default.
• W2018010902 hasConcept C2779993553 @default.
• W2018010902 hasConcept C2781253189 @default.
• W2018010902 hasConcept C2781413609 @default.
• W2018010902 hasConcept C2992694001 @default.
• W2018010902 hasConcept C3019249092 @default.
• W2018010902 hasConcept C501593827 @default.
• W2018010902 hasConcept C71924100 @default.
• W2018010902 hasConcept C86803240 @default.
• W2018010902 hasConcept C89423630 @default.
• W2018010902 hasConcept C90924648 @default.
• W2018010902 hasConceptScore W2018010902C126322002 @default.
• W2018010902 hasConceptScore W2018010902C2776551000 @default.
• W2018010902 hasConceptScore W2018010902C2778907293 @default.
• W2018010902 hasConceptScore W2018010902C2779454058 @default.
• W2018010902 hasConceptScore W2018010902C2779708577 @default.
• W2018010902 hasConceptScore W2018010902C2779993553 @default.
• W2018010902 hasConceptScore W2018010902C2781253189 @default.
• W2018010902 hasConceptScore W2018010902C2781413609 @default.
• W2018010902 hasConceptScore W2018010902C2992694001 @default.
• W2018010902 hasConceptScore W2018010902C3019249092 @default.
• W2018010902 hasConceptScore W2018010902C501593827 @default.
• W2018010902 hasConceptScore W2018010902C71924100 @default.
• W2018010902 hasConceptScore W2018010902C86803240 @default.
• W2018010902 hasConceptScore W2018010902C89423630 @default.
• W2018010902 hasConceptScore W2018010902C90924648 @default.
• W2018010902 hasIssue "3" @default.
• W2018010902 hasLocation W20180109021 @default.
• W2018010902 hasLocation W20180109022 @default.
• W2018010902 hasOpenAccess W2018010902 @default.
• W2018010902 hasPrimaryLocation W20180109021 @default.
• W2018010902 hasRelatedWork W1978366570 @default.
• W2018010902 hasRelatedWork W1979286787 @default.
• W2018010902 hasRelatedWork W1981244143 @default.
• W2018010902 hasRelatedWork W1987676275 @default.

• next